semaglutide and celiac disease How Future Pharmacologic Therapies for Will Complement the Gluten-Free Diet Common ground: shared risk factors

Freeman, A

GLP-1 receptor agonists are a class of medications originally developed for type 2 diabetes management and now some are also licensed for weight management

In high doses, it stimulates a strong antioxidant response in your body and also targets harmful cells or pathogens in your body, so it has been useful for chronic health conditions including cancer, chronic Lyme, and chronic infections

International Journal of Molecular Sciences , 23(5), p.2717

Alpha-MSH interacts with various melanocortin receptors (MCRs) in the body, affecting multiple physiological processes

"The medicines we acquired address autoimmune conditions, and they're largely biologics and are at an early stage of their life cycle," Bradway said